Carotenoids are pigments brought by fruit and vegetable consumption. While high intake of 21 fruits and vegetables were found to be associated with lower mortality, our objective is 22 investigate if total plasma carotenoid, via their antioxidant properties, are associated with 23 mortality risk in a free-living elderly population. The EVA study ("Epidemiology of Vascular 24
Introduction 41
Carotenoids are natural pigments, synthesized by plants and micro-organisms, but not 42 by animals nor by humans. These pigments are found in food, especially in fruits and 43 vegetables. Large epidemiological studies suggest a protective effect of high intake of fruits 44 and vegetables and all-cause mortality (1) (2) (3) (4) (5) . Consumption of fruits and vegetable could have a 45 protective effects on stroke and coronary heart diseases (6) (7) (8) (9) (10) . Concerning cancer, benefits of 46 fruits and vegetables intake are more controversial and the potential protective effect seems 47 depend of the type of cancer. Some studies did not showed evidence of strong association 48 with ovarian cancer (11) , breast cancer (12) , overall colon rectal cancer (13, 14) , renal cell 49 carcinomia (15) . However some studies suggest potential benefits of fruits and vegetable 50 consumption for some other cancer such as cancer of upper aero digestive tract (16) ,or lung 51 cancer (17, 18) .. 52
More information is needed to ascertain the association between the intake of single 53 nutrients, such as carotenoids, and the risk of all cause mortality. 54
The hypothetical protective role of carotenoids could come from their antioxidant 55 properties (19) . Literature on the implication of free-radicals in the aging process is well 56 documented (20, 21) but the relationship between total plasma carotenoid and mortality in free-57 living elderly populations via their antioxidant roles has not been previously studied. Other 58 underlying mechanisms such as inflammation mechanisms or immunoomodulatory 59 mechanisms could also be mentioned (19) . 60
Our objective is to explore the relationships between total plasma carotenoid at 61 baseline and 9-year mortality risk in a healthy elderly population 62 59-71 years) residing in the town of Nantes (western France) were recruited from electoral 67 rolls, and to a lesser extent, via information campaigns. All subjects were community 68 residents and underwent a complete examination in the EVA study centre where they spent 69 half a day. The last follow-up of the EVA study (EVA6) was conducted between June 2000 70
and December 2001. The study protocol was approved by the Ethical Committee of 71
University Centre Hospital of Kremlin-Bicêtre (Paris). Signed informed consent was obtained 72 from all participants at enrolment. 73
Data collection 74
Vital statistics and date and cause of death were collected throughout the 9 years of 75 follow-up. At each of the EVA steps, and at the end of the last year of study, the vital status of 76 individuals for whom we had no feedback was collected from town hall civil registries. The 77 cause of death was determined with the help of both the subject's general practitioner and 78 family. 79
At baseline, the general questionnaire allowed us to obtain information on socio-80 demographic factors such as sex, age, educational level (≤ primary school / ≥high school), 81 plus lifestyle habits like smoking habit (current, ex-smokers /non-smokers) and alcohol intake 82 (≥ 20ml / < 20ml per day). In addition, height and weight were measured. Two independent 83 measures of systolic and diastolic blood pressure were taken with a digital electronic 84 tensiometer (SP9 Spengler) after a 10-minute rest. Cognitive performances were assessed 85 using the Mini Mental Status Examination (MMSE) (24) . Blood samples were collected 86 between 8:30 am and 9:30 am after a 12 hour fast. Total plasma cholesterol, and plasma 87 glucose levels were measured using standard methods. 88
Health characteristics considered in this analysis were MMSE score, BMI, diabetes 89 status (plasma glucose level ≥ 7.80 mmol/L , use of anti-diabetic drugs or diabetes medical 90 history), dyslipidemia (total cholesterol ≥ 6.20 mmol/L, use of lipid-lowering drugs or 91 dyslipidemia medical history), hypertension (systolic or diastolic blood pressure ≥ 140 or ≥ 90 92 mm Hg respectively, or use of hypertensive drugs or hypertension medical history), history of 93 vascular diseases (self-reported history of myocardial infarction, angina pectoris, stroke). 94 and measurements of absorbance on the hexane phase at 350, 450 and 550nm were performed 98 (spectrophotometer Uvikon 860, Kontron, Rotkreuz, Switzerland). Concentrations were 99 calculated on the basis of a molecular extinction factor at 450 nm of 134,000 L/mol/cm. 100
Absorbance values at 350 and 550 nm were used to correct the absorbance obtained at 450 nm 101 by applying an adequate equation. Coefficients of intra-and inter-assay variations were 5.4% 102 and 4.9%, respectively. 103
Thiobarbituric acid-reactive substances (TBARS) and plasma selenium determination 104
Plasma levels of TBARS were determined by a fluorometry method as described by Richard 105 et al. (25) and described previously (26) . Selenium was determined in serum using 106 electrothermal atomic absorption spectrometry (Perkin Elmer 5100 ZT, Norwalk, CT, USA) 107 according to Arnaud et al. (27) and described previously (22) . 108 109
Statistics 110
Survival was analyzed with actuarial methods, and Wilcoxon tests were used to 111 compare survival between total plasma carotenoid quintile groups. Association between total 112 plasma carotenoid and mortality were determined by Cox proportional hazards regression 113 models in which year of age during the study was used as time axis, with left truncation at the 114 age of study entry. Multivariate analyses were adjusted for potential confounding variables 115 and similar analyses were repeated after additionally taking into account TBARS levels and 116 plasma selenium levels (analysed as continuous variables). The proportional hazards 117 assumption was verified by adding a time-dependent variable to the model (28) . In these 118 analyses, total plasma carotenoid level was considered by quintiles defined in each sex and 119 was also considered as a continuous variable when the strength of analyses was too small to 120 allow a categorical treatment. Results of Cox multivariate regressions were expressed by 121
Hazard Ratio (HR) with their confidence interval (CI) at 95 %. All interactions between total 122 plasma carotenoids and other variables were tested. Statistical analyses were performed using 123 SAS software version 9.1 (SAS Institute, Inc. Cary, North Carolina). 124
125
Results
126
Of the 1389 study participants included in the analyses, 1283 had measurements of total 127 plasma carotenoid and complete information on covariables. Characteristics according to sex 128 were described in Table 1 . During the 9-year follow-up, 93 death occurred with a higher rate 129 in men than in women (n=61 in men n=32 in women, p=<10-4). A higher mortality rate was 130 observed in current and former smoker, in regular alcohol consumer, in participants with low 131 concentration of plasma selenium and with high BMI and participants with diabetes, 132 hypertension and cardiovascular diseases (results not showed). 133
Total plasma carotenoid level was significantly higher in women (m=3.08 (SD=1.33) 134 µmol/L) than in men (m=2.19 (SD=0.99) µmol/L) (table 1) and a discrepancy in the 135 distribution was observed between men and women (figure 1). 136 137 Means of total plasma carotenoid were significantly higher in surviving individuals 138 (m=2.75 (SD=1.27) µmol/L) than in those who died (2.12 (SD=1.12) µmol/L, p<10-4). This 139 association was found to be gender dependant. The relationship was found to be significant 140 for men (m=2. 24 At baseline, a significant association was observed between concentration of plasma 154 carotenoid and education level in women (lower concentrations observed in women with low 155 education level) and marital status in men (higher concentration in married men). In both 156 sexes, a lower total plasma carotenoid concentration was also observed in participants who 157 were regular alcohol consumers, in participants with diabetes, hypertension, cardiovascular 158 disease history and a higher concentration was observed in dyslipidemic participants. Plasma 159 carotenoids concentrations were also negatively correlated with BMI and positively correlated 160 with plasma selenium in both sexes and with TBARS levels in women. 161 analysed after adjustment for all factors associated with mortality or /and with total plasma 163 carotenoid in each sex separately, results are presented in The present study shows that low total plasma carotenoid level was significantly 192 associated with all-cause mortality and mortality by cancer, in men but not in women after 193 controlling for the main potential confounding factors. We also highlighted that this 194 association was independent of plasma selenium level, that was found to be significantly 195 associated with all cause mortality in this population (22) . 196
The EVA study included a large number of volunteers, whose educational status and 197 cognitive function levels are known to be linked with mortality risks and this proportion is 198 higher in the EVA cohort than in the average French elderly population. Despite this 199 selection, total plasma carotenoid concentrations were within the same ranges as those of 200 different European populations. 201
The lower total plasma carotenoid concentrations in men compared to women in our 202 cohort has been described in several epidemiological studies (29, 30) especially for β-carotene 203 (31, 32) . Regarding to the large discrepancy in the distribution of total plasma carotenoid 204 concentration between the two sex, as the threshold of the lowest quintile in women (<2.0 205 µmol/L) was about the median in men, the lack of evidence of association between total 206 plasma carotenoid concentration and mortality in women could be explained by the fact that it 207 is only participants with very low levels who have higher risk of mortality. Additionally, the 208 higher number of death observed in men than in women (61 versus 32) could also participate 209 to the non evidence of an association in women. This difference of concentrations of plasma 210 carotenoid between men and women could result from a higher fruit and vegetable intake in 211 women than in men explainable by exogenous factors such as socio-cultural factors leading to 212 better dietary habits in women -a gender difference -but we can not exclude the effect of 213 endogenous factors in the hormonal differences or lipid and nutrient transport differences (33) -214 a sex difference -. Anyway, the differences between men and women for carotenoid 215 distributions and mortality rate led us to conclude that only stratified analyses on sex should 216 be undertaken to investigate and better understand relationships between plasma carotenoid 217 level and mortality risk. 218
Our finding was supported by results from the MacArthur studies on Successful Aging 219 (34) , in which low levels of serum β-carotene (≤0.17 µmol/L=median value) were significantly 220 associated with the 7-year all-cause mortality in men (OR=2.30 (1.23; 4.31)) but not in 221 women (OR=0.85 (0.42; 1.75)). In the Women's Health and Aging studies (n=632, 70-79 222 years) (35) a significant link was found in women between higher total serum carotenoid and a 223 lower risk of mortality (for 1 SD increase of log tot. carotenoid, RR=0.77 (0.64;0.84)), however we noted in this study, that women's geometric means of total serum carotenoid 225 were very low (m=1.63 µmol/L). In non stratified analyses, two other studies showed an 226 associations between high levels of carotenoids compounds and lower mortality risk. First, in 227 the European study SENECA (n=1168, 70-75 years) (36) in which plasma carotene 228 concentrations were significantly associated with mortality risk (for an increment of 0.39 229 µmol/L, RR=0.79(0.70 ;0.89)). Second, in a study on 638 independently living elderly 230 subjects aged 65-85 year (29) , analyses of tertiles of carotenoids showed a significant link 231 between all-cause mortality and xanthophylls carotenoids, but not with total serum carotenoid 232 even if tests for trends were significant (p=0.02). Discordance of the results according to the 233 carotenoids compounds studied could came from the fact that all carotenoids compounds have 234 not the same biological properties. Finally in another study led by Fletcher et al. on 1214 235 subjects (75-84 years) (37) , the relationship between plasma β-carotene and all-cause mortality 236 during the 4.4-year follow-up did not remain statistically significant after adjustment for 237 potential confounding factors. The absence of a significant link could be explained by a sex 238 effect, which was not reported, or by the advanced age of the population or more probably by 239 relatively higher baseline levels of plasma β-carotene in this population. 240
241
Concerning the randomized trials, two randomised controlled trials led in general 242 population have investigated supplementation effects on incidence of cancer and all-cause 243 mortality (33, 38) . In the Linxian trial conducted on 29584 adult subjects (38) a significantly 244 lower 5-year total mortality risk occurred among those receiving supplementation with beta 245 carotene, vitamin E, and selenium. In the primary prevention trial SUVIMAX including 246 13017 French adults (33) a significant protective effect of 7.5-years combined antioxidant 247 including β-carotene supplementation on all-cause mortality was observed in men but not in 248 women. In this trial, the effect of supplementation was also studied after stratification on 249 initial antioxidant plasma levels. A net benefit was observed only in men with a low status of 250 β-carotene or ascorbate but not in women (39) . However, in these combined multi antioxidant 251 supplementation studies, it is impossible to isolate the proper effect of carotenoids on 252 mortality. However, the recent meta analyses led by Bjelakovic et al. (40) , carried on 68 253 randomised trials with 232606 participants, showed that supplementation of beta-carotene 254 singly or combined significantly increased mortality. One explanation would be that instead 255 having role in the pathogenesis of many chronic diseases, oxidative stress may be a 256 consequence of pathological conditions. By eliminating free radicals from our organism, we 257 interfere with some essential defensives mechanisms (40) . In this meta-analyse authors did not 258 take into account sex as covariable which could influence the intervention effect across the 259 trials and constitutes a limitation for interpreting their results. 260 261 When considering the underlying causes of death, we found a significant association 262 between low total plasma carotenoid and higher cancer mortality in men. Our results should 263 be viewed with some caution, given that only 45 cancer deaths occurred. While low intake or 264 having a low serum concentration of beta-carotene was suggested to be associated with 265 elevated risk of cancer by epidemiological studies (41) and by one large randomised trial 266 conducted in China, in the early 1980s (38) , the results of recent trials call back to cautious 267 concerning the potential benefit of supplementation of carotenes, by showing a higher rate of 268 lung cancer in smoker participants who received a supplements containing beta-carotene 269 compared to those receiving placebo in the ATBC Study (42) (43) (44) . Then, association between 270 carotenoid and cancer seems to be specific of cancer site. Our data did not allow investigating 271 associations between total plasma carotenoid on specific cancer site. . 272
273
In a previous study, we showed a significant association between low plasma selenium 274 levels and all-cause mortality risk and cancer mortality in both sexes (22) . In the present 275 analyses, after adjustment on plasma selenium levels, associations between total plasma 276 carotenoid and mortality risk remained statistically significant, suggesting that plasma 277 selenium and plasma carotenoid have each of them a proper protective effect on mortality 278 risk. This result was supported by the Women's Health and Aging Studies results (35) . 279 280 Currently, the mechanism of this potential relationship is still under debate and, as it 281 has been described by Paiva et al., several hypotheses can explain this observation (19) . One of 282 them involves the antioxidant properties. In our study, analyses were repeated after 283 controlling on TBARS levels, a lipidoperoxidation marker; our results remained unchanged 284 suggesting that the association between total plasma carotenoid on mortality observed in our 285 cohort did not arise from an antioxidant protection. However the oxidative stress marker role 286 of TBARS seems controversial and we have to remain cautious with such a conclusion even 287 if, in a placebo controlled single blind study, Hininger et. al, showed that carotenoid 288 supplementation (lutein, lycopene, β-carotene) did not lead to a significantly measurable 289 improvement in antioxidant defences in apparently healthy subjects (n=175, 25-45 years) (45) . 290
The other underlying mechanism by which low carotenoid could contribute to an increased 291 risk of mortality may be related to inflammation. In the MacArthur Studies of Successful C reactive protein and interleukin 6 levels, and they showed an independent and synergic 294 effect between low β-carotene concentrations and high inflammation burden on mortality risk 295 (34) . Unfortunately, inflammation markers were not available in our study. Finally, two other 296 mechanisms were also mentioned, on one hand, a possible pro-inflammatory and 297 immunomodulatory mechanism is hypothesized by the carotenoid's activation of 298 lipoxygenases activities (19) . On the other hand, it has been suggested that carotenoids may 299 also be involved in the activation of gene expression, which encodes the message for an 300 element of gap junction (connexin 43) required for cell to cell communication (19) . To our 301 knowledge, neither the activity of lipoxygenases, nor measurements of connexin 43 have ever 302 been taken into account in epidemiological studies interested in the relationship between 303 carotenoids and chronic diseases or mortality in general populations. So, at this point, it seems 304 difficult to be more precise on the mechanism by which carotenoids could act. Finally, we 305 cannot exclude that carotenoids in our study might have been serving as markers for other 306 protective factors present in fruits and vegetables, but that are not acting as effective agents 307 themselves. Further biological research is necessary to confirm the association between 308 carotenoids and mortality particularly in elderly subjects, to better understand the action 309 mechanism, and so to be able to determine if the protective association of carotenoids on 310 mortality found in men but not in women is only a random effect, a sex or a gender 311 difference. 312
By showing, prospectively, in a general healthy elderly population, that total plasma 313 carotenoid levels were an independent associated marker of mortality in men after taking into 314 account potential confounding factors, our study suggests that total plasma carotenoid levels 315 could be a "healthy diet" indicator in elderly populations. Further studies are necessary to 316 explore the mechanism which could explain the relationship. 317
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